IARC Group 2B: possibly carcinogenic to humans
IARC evaluated the sodium salt specifically in its 1987 Supplement 7 and again in Volume 73 (1999), concluding there is sufficient evidence of carcinogenicity in animals and classifying it as Group 2B, possibly carcinogenic to humans. The parent compound ortho-phenylphenol is Group 3 (not classifiable). No human cancer data were available at either evaluation.
Sodium ortho-phenylphenate is classified as possibly carcinogenic to humans (IARC Group 2B) based on sufficient evidence of carcinogenicity in experimental animals.
1999RegulatoryIARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 73
Dietary administration produced tumours of the urinary bladder and renal pelvis in male rats in two separate studies, and a marginal increase in bladder tumours in female rats in one study. No carcinogenicity was observed in mice.
1999AnimalIARC Monographs, Volume 73, ortho-Phenylphenol and its Sodium Salt
In the earlier Supplement 7 assessment, the sodium salt was also noted to increase liver haemangiomas and hepatocellular carcinomas in male mice following oral administration.
1987AnimalIARC Monographs Supplement 7, Sodium ortho-Phenylphenate
Mechanism: bladder irritation and cell proliferation, not direct DNA damage
Animal studies indicate the sodium salt acts through a non-genotoxic mechanism. High doses raise urinary pH and produce toxic metabolites including phenylhydroquinone and phenylbenzoquinone, which cause urothelial cell damage and persistent inflammation, leading to regenerative cell proliferation. Tumours develop only at doses that first produce this hyperplasia. No DNA adduct formation was detected in rat bladder tissue, which suggests the carcinogenic pathway does not involve direct genetic damage.
No evidence of direct DNA adduct formation was found in rat bladder urothelium exposed to ortho-phenylphenol or the sodium salt, supporting a non-genotoxic mode of action.
2001Lab + animalDietrich, Toxicological Sciences, Oxford Academic
The higher urinary pH induced by the sodium salt, compared with the parent compound, may enhance urothelial toxicity; formation of abnormal urinary crystals was not part of the mechanism.
1999AnimalIARC Monographs, Volume 73
Reactive quinoid metabolites, particularly phenylbenzoquinone, have been identified as the likely drivers of cytotoxicity and subsequent cell proliferation in rat bladder epithelium.
1983LabMolecular mechanisms involved in the toxicity of orthophenylphenol and its sodium salt, ScienceDirect
Human relevance disputed: species-specific, high-dose effect
Toxicologists have debated whether the rat bladder tumour findings translate to humans. The dominant view in the regulatory literature is that the effect is species-specific and dose-dependent, occurring only at levels far above any food residue exposure, and involving a threshold-based non-genotoxic pathway. JECFA set an ADI of 0 to 0.4 mg/kg bodyweight for 2-phenylphenol (the active form the sodium salt converts to), reflecting this threshold view. No human epidemiological data have linked dietary exposure to cancer.
Bladder tumours in rats and male mice are considered high-dose, sex- and species-specific phenomena based on non-genotoxic mechanisms, and conventional margin-of-safety approaches are judged appropriate for human risk assessment.
2003Regulatory reviewO-phenylphenol and its sodium and potassium salts: a toxicological assessment, PubMed PMID 12487365
JMPR (1999) established an ADI of 0 to 0.4 mg/kg bodyweight for 2-phenylphenol; the sodium salt was not given a separate ADI because it dissociates rapidly to the parent compound.
1999RegulatoryJMPR Evaluation 1999, FAO/WHO
No data were available to the IARC Working Group on carcinogenicity of either ortho-phenylphenol or its sodium salt in humans.
1999RegulatoryIARC Monographs, Volume 73
Removed from EU and UK permitted food additive lists
Neither the EU Regulation 1333/2008 Annex II nor the current UK FSA approved-additives list includes E232. E230, E231, E232 and E233 all have a gap in the permitted preservatives series, with the list jumping from E228 to E234. Some EU member states retained E232 as a post-harvest plant protection product under separate pesticide law after it was removed as a food additive, regulated by maximum residue levels rather than additive authorisation.
E232 is absent from the UK FSA approved-additives list and from Annex II of EU Regulation 1333/2008; it is not a permitted food additive in the UK or EU.
RegulatoryUK FSA Approved Additives and E Numbers, food.gov.uk
A provisional MRL of 5 mg/kg was set for 2-phenylphenol residues on citrus fruits under EU Regulation 396/2005, covering post-harvest use as a plant protection product in countries where it remains authorised.
2017RegulatoryEFSA Review of existing MRLs for 2-phenylphenol, EFSA Journal